Abstract
Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the recent availability of improved molecular diagnostic tools have revolutioned the management of HIV/HBV coinfected patients. The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B.
Original language | English (US) |
---|---|
Pages (from-to) | 1399-1410 |
Number of pages | 12 |
Journal | AIDS |
Volume | 22 |
Issue number | 12 |
DOIs | |
State | Published - Jul 31 2008 |
Keywords
- Drug resistance
- HIV
- Hepatitis B
- Hepatitis B virus
- Liver
- Tenofovir
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases